In a series of experiments, scientists reactivated resting immune cells that were latently infected with HIV or its monkey relative, SIV, in blood cells and a variety of tissues in animals. As a result, the cells started making copies of the viruses, which could be neutralized by anti-HIV drugs and the immune system. This breakthrough, published in January 2020 in two articles in the journal Nature, marks progress towards widely accessible treatment for HIV.